| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Revolution Medicines, Inc. (RVMDW) has 5 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 299.9K | $2.07M | - | |
| COO | 184.2K | $1.27M | -90,000 | |
| Other | 55.8K | $385.4K | - | |
| Other | 47.0K | $324.1K | - | |
| Dir | 15.0K | $103.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | Horn Margaret A48 | Chief Operating Officer | Sale+OE | 93,575 | $160.00 | $14,972,110.02 | -16.7% | - | - | |
| Apr 27, 2026 | Mancini Anthony | See Remarks | Sale+OE | 3,120 | $132.41 | $413,128.80 | -1.9% | - | - | |
| Apr 15, 2026 | Goldsmith Mark A52 | See Remarks | Sale+OE | 120,000 | $150.09 | $18,010,488.00 | -30.2% | - | - | |
| Mar 25, 2026 | Mancini Anthony | See Remarks | Sale+OE | 37,450 | $95.56 | $3,578,820.58 | -9.6% | +267.0% | - | |
| Jan 21, 2026 | Cislini Jeff | General Counsel | Sell | 908 | $115.60 | $104,964.80 | -1.9% | - | - |